Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(27%)
Results Posted
33%(1 trials)

Phase Distribution

Ph early_phase_1
1
9%
Ph phase_1
2
18%
Ph phase_3
1
9%
Ph not_applicable
7
64%

Phase Distribution

3

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 1Safety & dosage
2(18.2%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
7(63.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(8)
Completed(3)

Detailed Status

Not yet recruiting4
Completed3
Active, not recruiting2
Enrolling by invitation1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (9.1%)
Phase 12 (18.2%)
Phase 31 (9.1%)
N/A7 (63.6%)

Trials by Status

active_not_recruiting218%
enrolling_by_invitation19%
completed327%
not_yet_recruiting436%
recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11